Boehringer Ingelheim (Group)

http://www.boehringer.com

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 143 affiliates in 47 countries and almost 37,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In 2005, Boehringer Ingelheim posted net sales of 9.5 billion euro while spending almost one fifth of net sales in its largest business segment Prescription Medicines on research and development. *

	Start	1885-01-01 established
	Industry	pharmaceutical

	Region	Ingelheim
	Country	Germany
	Street	173 Binger Str.
	City	55216 Ingelheim
	Tel	+49-6132-770
	Fax	+49-6132-77-3000
		Address record changed: 2008-12-07

Basic data	Employees	H: 10,001 to 50,00 (2006-12-31)
	Currency	EUR
	Annual sales	10,574,000,000 (net sales, consolidated (2006) 2006-12-31)
	Profit	1,722,000,000 (2006-12-31)
	Cash	866,000,000 (2006-12-31)

		* Document for »About Section«: Boehringer Ingelheim. (11/10/06). "Press Release: FDA Approves Boehringer Ingelheim’s Pramipexole for the Treatment of Moderate-to-severe Primary Resteless Legs Syndrome (RLS). Millons of People Worldwide Living with RLS to Benefit as Treatment Becomes g

		Record changed: 2012-05-19

Follow Us!

Top News

Upcoming Events

Associations

Partners

Boehringer Ingelheim (Group)

More documents for Boehringer Ingelheim (Group)